These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20859697)

  • 1. Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA--a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas.
    Pal A; Balatoni JA; Mukhopadhyay U; Ogawa K; Gonzalez-Lepera C; Shavrin A; Volgin A; Tong W; Alauddin MM; Gelovani JG
    Mol Imaging Biol; 2011 Oct; 13(5):853-61. PubMed ID: 20859697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.
    Yeh HH; Ogawa K; Balatoni J; Mukhapadhyay U; Pal A; Gonzalez-Lepera C; Shavrin A; Soghomonyan S; Flores L; Young D; Volgin AY; Najjar AM; Krasnykh V; Tong W; Alauddin MM; Gelovani JG
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1603-8. PubMed ID: 21220318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of nonsmall cell lung carcinomas expressing active mutant EGFR kinase using PET with [(124)i]-morpholino-IPQA.
    Yeh SH; Lin CF; Kong FL; Wang HE; Hsieh YJ; Gelovani JG; Liu RS
    Biomed Res Int; 2013; 2013():549359. PubMed ID: 23956990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.
    Tian M; Ogawa K; Wendt R; Mukhopadhyay U; Balatoni J; Fukumitsu N; Uthamanthil R; Borne A; Brammer D; Jackson J; Mawlawi O; Yang B; Alauddin MM; Gelovani JG
    J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR).
    Fawwaz M; Mishiro K; Nishii R; Sawazaki I; Shiba K; Kinuya S; Ogawa K
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.
    Pal A; Glekas A; Doubrovin M; Balatoni J; Namavari M; Beresten T; Maxwell D; Soghomonyan S; Shavrin A; Ageyeva L; Finn R; Larson SM; Bornmann W; Gelovani JG
    Mol Imaging Biol; 2006; 8(5):262-77. PubMed ID: 16897320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and preliminary evaluation of
    Lu X; Wang C; Li X; Gu P; Jia L; Zhang L
    Bioorg Med Chem; 2019 Feb; 27(3):545-551. PubMed ID: 30611635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy.
    Makino A; Miyazaki A; Tomoike A; Kimura H; Arimitsu K; Hirata M; Ohmomo Y; Nishii R; Okazawa H; Kiyono Y; Ono M; Saji H
    Bioorg Med Chem; 2018 May; 26(8):1609-1613. PubMed ID: 29478801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.
    Su H; Seimbille Y; Ferl GZ; Bodenstein C; Fueger B; Kim KJ; Hsu YT; Dubinett SM; Phelps ME; Czernin J; Weber WA
    Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1089-99. PubMed ID: 18239919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).
    Ullrich RT; Zander T; Neumaier B; Koker M; Shimamura T; Waerzeggers Y; Borgman CL; Tawadros S; Li H; Sos ML; Backes H; Shapiro GI; Wolf J; Jacobs AH; Thomas RK; Winkeler A
    PLoS One; 2008; 3(12):e3908. PubMed ID: 19079597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and biological evaluation of
    Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147-mediated glucose metabolic regulation contributes to the predictive role of
    Li X; Fu Q; Zhu Y; Wang J; Liu J; Yu X; Xu W
    Mol Carcinog; 2019 Feb; 58(2):247-257. PubMed ID: 30320488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC.
    Xiao Z; Song Y; Kai W; Sun X; Shen B
    Oncotarget; 2017 Jun; 8(25):40732-40740. PubMed ID: 28489575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma.
    Fawwaz M; Mishiro K; Nishii R; Makino A; Kiyono Y; Shiba K; Kinuya S; Ogawa K
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33809064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step radiosynthesis of
    Xiao Z; Song Y; Wang K; Sun X; Shen B
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5985-5988. PubMed ID: 27825546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.
    Tracy S; Mukohara T; Hansen M; Meyerson M; Johnson BE; Jänne PA
    Cancer Res; 2004 Oct; 64(20):7241-4. PubMed ID: 15492241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents.
    Neto C; Fernandes C; Oliveira MC; Gano L; Mendes F; Kniess T; Santos I
    Nucl Med Biol; 2012 Feb; 39(2):247-60. PubMed ID: 22079040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography.
    Slade RL; Pisaneschi F; Nguyen QD; Smith G; Carroll L; Beckley A; Kaliszczak MA; Aboagye EO
    PLoS One; 2016; 11(8):e0161427. PubMed ID: 27552105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosynthesis and Biological Evaluation of [
    Litchfield M; Wuest M; Glubrecht D; Wuest F
    Mol Pharm; 2020 Jan; 17(1):251-261. PubMed ID: 31816246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.